注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Summit Therapeutics Inc是一家生物製藥公司。該公司專註於發現、開發和商業化治療嚴重傳染病的抗生素。其主要的CDI候選產品是利迪拉唑,是一種口服的小分子抗生素。該公司的臨床前候選產品包括SMT-738,來自DDS-04系列,用於對抗耐多藥感染,特別是耐碳青黴烯的腸桿菌科(CRE)感染。該公司正在開展一項III期臨床項目,重點是治療艱難梭狀芽孢桿菌感染,也稱為艱難梭狀芽孢桿菌感染(CDI)的患者。該公司還在尋求通過開發一種新的機製,利用其Discuva平臺的精確抗生素來擴大其候選產品組合。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Francesco Muntoni | - | - | Member of Scientific Advisory Board |
Edith Sim | - | - | Member of Scientific Advisory board |
Bob Sim | - | - | Member of Scientific Advisory board |
Roger Patient | - | - | Member of Scientific Advisory Board |
Derek Stemple | - | - | Member of Scientific Advisory board |
William Graham Richards | 84 | - | Member of Scientific Advisory board |
Jean-Paul Vincent | - | - | Member of Scientific Advisory board |
Marcel van den Heuvel | - | - | Member of Scientific Advisory Board |
Ujwala Mahatme | 58 | 2020 | Independent Non-Executive Director |
Yu Xia | 56 | 2023 | Director |
Mahkam Zanganeh | 54 | 2020 | Co-CEO, President & Director |
Robert W. Duggan | 79 | 2019 | Co-CEO & Executive Chairman |
Kenneth A. Clark | 65 | 2021 | Lead Independent Director |
Robert F. G. Booth | 70 | 2022 | Independent Director |
Alessandra Cesano | 63 | 2022 | Independent Non-Executive Director |
Dame Kay Davies | 73 | - | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
Manmeet Singh Soni | 46 | 2019 | COO, CFO & Director |
Mostafa Ronaghi | 55 | 2024 | Independent Independnet Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核